{"nct_id":"NCT05508789","title":"A Study of Donanemab (LY3002813) in Participants With Early Symptomatic Alzheimer's Disease (TRAILBLAZER-ALZ 5)","status":"RECRUITING","status_verified_date":"2025-10","start_date":"2022-10-10","start_date_type":"ACTUAL","primary_completion_date":"2028-05","primary_completion_date_type":"ESTIMATED","completion_date":"2028-07","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["LLY"]}